IP Library Granted Patent US 7,410,776
Granted Patent B2
US 7,410,776 · App. 10/184,722 · Granted Aug 12, 2008

Polypeptides, their production and use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,410,776
App. No.
10/184,722
Granted
Aug 12, 2008
Kind
B2
Abstract

This invention relates to a novel polypeptide involving in the modulation of central nervous system function, circulatory function, immune function, gastrointestinal function, metabolic function, reproductive function, etc., it can be used as a drug for treating or preventing a variety of diseases, e.g. HIV infection or AIDS (acquired immune deficiency syndrome) or the like.

Claims (4)

1. An isolated DNA comprising a nucleotide sequence coding for a ligand polypeptide capable of binding to a receptor protein, wherein the receptor protein comprises the amino acid sequence of SEQ ID NO: 3, and wherein the ligand polypeptide comprises the amino acid sequence of SEQ ID NO: 40.

2. A recombinant vector which comprises the DNA as claimed in claim 1 .

3. A transformant carrying the DNA as claimed in claim 1 or the recombinant vector as claimed in claim 2 .

4. A method for producing a polypeptide, a precursor polypeptide thereof or a salt thereof which comprises cultivating the transformant as claimed in claim 3 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2007
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 019013/0140 →